Femasys (FEMY)
(Delayed Data from NSDQ)
$0.93 USD
-0.04 (-3.78%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $0.92 -0.01 (-1.30%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Femasys Inc. has a market cap of $31.51M, which represents its share price of $0.97 multiplied by its outstanding shares number of 32.53M. As a small-cap company, FEMY's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
FEMY 0.93 -0.04(-3.78%)
Will FEMY be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for FEMY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for FEMY
Vir Biotechnology, Inc. (VIR) Reports Q2 Loss, Lags Revenue Estimates
Femasys Inc. (FEMY) Reports Q1 Loss, Misses Revenue Estimates
FEMY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Curis (CRIS) Reports Q1 Loss, Tops Revenue Estimates
BioMarin Pharmaceutical (BMRN) Beats Q1 Earnings and Revenue Estimates
Femasys Inc. (FEMY) Reports Q4 Loss, Lags Revenue Estimates
Other News for FEMY
Femasys secures first European order for FemBloc
Femasys Secures First European Order for FemBloc, Marking Strategic Milestone in Global ...
Femasys secures first European order for FemBloc
Femasys announces achievement of regulatory approvals in Australia, NZ
Femasys Gains Momentum with EU Approval and Strategic Partnerships, Justifying Buy Rating